Formalizing the boundaries between predictive manifold modeling and clinical decision-making. Version 30.0 | Build 0x300_v30.
The Zenith Institutional Platform is intended solely for Computational Target Prioritization and In-Silico Protocol Optimization in pre-clinical longevity research.
"The system facilitates the identification of high-probability therapeutic targets by modeling transcriptomic trajectories using the Zenith ~500M parameter manifold. It provides a decision-support framework to reduce cycle time in institutional validation."
Status: Research Use Only (RUO). Not for use in human diagnostic procedures.
The NEUROS-X Safety Engine uses a 512-neuron spiking cardiac substrate to audit candidate reprogramming cocktails for arrhythmia risk (Long QT, CPVT) in silico prior to wet-lab LNP formulation and animal validation.
Normal ECG synchrony and action potential integration. Approved for wet-lab validation.
Partial conduction block detected. Automated Bayesian dosage optimization recommended.
Action potential failure. Candidate cocktail blacklisted. Alternative factors suggested.
POST /api/v1/neural/analyze
External audit of Zenith Ultra v30.0 parameter stability. Benchmarked for 99.8% fidelity against the Institutional Specialist dataset.
Publication of cross-dataset validation study comparing Zenith trajectories to dry-lab and wet-lab outcomes.
GDPR/HIPAA compliant ingestion layers. All institutional training data is anonymized and source-verified.
Internal ISO 13485 framework adoption for the Zenith v30.0 development lifecycle (SDLC).
Phase 4 Validated build for Zenith Ultra core architecture.
Download the comprehensive regulatory manifest for institutional review.